Cellular origin of glioblastoma and its implication in precision therapy

Cell Mol Immunol. 2018 Aug;15(8):737-739. doi: 10.1038/cmi.2017.159. Epub 2018 Mar 19.

Maojin Yao¹, Shu Li², Xiaojun Wu³, Shuo Diao^{1

4}, Guoxin Zhang⁵, Hua He^{6

7}, Liuguan Bian⁸, Yicheng Lu³

¹ Department of Microbiology, Immunology and Cancer Biology, School of Medicine, University of Virginia, Charlottesville, 22903, VA, USA.
² Department of Pathophysiology, Wannan Medical College, Wuhu, 241002, China.
³ Department of Neurosurgery, Changzheng Hospital, Second Affiliated Hospital of Second Military Medical University, 415 Fengyang Road, Shanghai, 200003, People's Republic of China.
⁴ Department of Neurosurgery, First Affiliated Hospital, Dalian Medical University, Dalian, 116044, People's Republic of China.
⁵ Brain Tumor Institute, University of California, San Diego, 92093-0695, CA, USA.
⁶ Department of Neurosurgery, Changzheng Hospital, Second Affiliated Hospital of Second Military Medical University, 415 Fengyang Road, Shanghai, 200003, People's Republic of China. [email protected].
⁷ State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Beijing, 201203, China. [email protected].
⁸ Department of Neurosurgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. [email protected].

No abstract available

Publication types